Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Symrise AG    SY1   DE000SYM9999

SYMRISE AG

(SY1)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Symrise: Hydrolite® 5P- multifunctional excipient suitable for pharmaceutical applications

share with twitter share with LinkedIn share with facebook
08/12/2020 | 04:37am EDT

25 years after the launch of its multifunctional ingredient Hydrolite® 5, Symrise is now launching its pharmaceutical grade Pentylene Glycol, Hydrolite® 5P. A Drug Master File (DMF) is available for this product, which will introduce the benefits of Hydrolite®5 green to the pharmaceutical and dermo-cosmetic industries. The ingredient uses a by-product of the sugar cane industry and brings sustainable benefits from a renewable source.

"Hydrolite® 5P hydrates the skin and bolsters the efficacy of active ingredients used in the formulations" says Najeeb Hakimi, Product Manager at Symrise. "With Hydrolite® 5P, our customers can improve the efficacy of formulations with the same dose of active ingredients." Hydrolite® 5P enhances formulation esthetics and improves the skin feel of formulations. And because it can aid the product protection system, it helps reduce the amount of preservatives used in a product.

Hydrolite® 5P is entirely made from the by-product from the sugar cane industry. It perfectly fits into the sustainability strategy of Symrise. Within this strategy, the company emphasizes the importance of comprehensive transparency that benefits customers and end consumers.

.

(C) 2020 M2 COMMUNICATIONS, source M2 PressWIRE

share with twitter share with LinkedIn share with facebook
All news about SYMRISE AG
09/24SYMRISE AG : Baader Bank reiterates its Buy rating
MD
09/23SYMRISE : Division Diana Food launches the first clean label, organic and Fair T..
PU
09/23SYMRISE AG : Berenberg remains Neutral
MD
09/11SYMRISE : advances sustainable packaging
AQ
09/09NEW CLINICAL DATA SUGGESTS : Symrise anti-dandruff active promotes healthy scalp..
AQ
09/07SYMRISE AG : UBS reaffirms its Neutral rating
MD
09/04SYMRISE AG : Baader Bank reiterates its Buy rating
MD
09/01SYMRISE AG : UBS sticks Neutral
MD
08/31SYMRISE : Atos and Symrise extend contract to advance digitalization with innova..
AQ
08/27PROBI : New clinical results on stress from Probi and their probiotic strain L. ..
AQ
More news
Financials
Sales 2020 3 620 M 4 224 M 4 224 M
Net income 2020 345 M 402 M 402 M
Net Debt 2020 1 371 M 1 600 M 1 600 M
P/E ratio 2020 47,8x
Yield 2020 0,88%
Capitalization 15 913 M 18 546 M 18 571 M
EV / Sales 2020 4,78x
EV / Sales 2021 4,48x
Nbr of Employees 10 413
Free-Float 91,2%
Chart SYMRISE AG
Duration : Period :
Symrise AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SYMRISE AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 105,57 €
Last Close Price 117,50 €
Spread / Highest target 13,2%
Spread / Average Target -10,2%
Spread / Lowest Target -31,1%
EPS Revisions
Managers
NameTitle
Heinz-Jürgen Bertram Chief Executive Officer
Michael König Chairman-Supervisory Board
Olaf Klinger Chief Financial Officer
Horst-Otto Gerberding Member-Supervisory Board
Peter Winkelmann Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
SYMRISE AG25.27%18 546
ECOLAB INC.2.74%56 583
GIVAUDAN SA30.06%39 532
SIKA AG21.91%34 016
EMS-CHEMIE HOLDING AG30.71%21 156
CRODA INTERNATIONAL PLC21.48%10 222